Nouscom Aims To Ride Neoantigen Cancer Vaccine Wave

Nouscom, with one major partner and strong confidence, is building research and manufacturing foundations to address significant market needs with its neoantigen cancer vaccine platform. 

Neoantigen-Based Cancer Vaccines Are Generating More Encouraging Data • Source: Shutterstock

More from Innovation

More from In Vivo